The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43
Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Huelga, S. C., Moran, J., Liang, T. Y., Ling, S.-C., Sun, E., Wancewicz, E., Mazur, C., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2779 · Cited by 1,335
The chemical evolution of oligonucleotide therapies of clinical utility
Khvorova, A., & Watts, J. K. (2017) · Nature Biotechnology · doi:10.1038/nbt.3765 · Cited by 1,216
Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs
Lagier-Tourenne, C., Polymenidou, M., Hutt, K. R., Vu, A. Q., Baughn, M., Huelga, S. C., Clutario, K. M., Ling, S.-C., Liang, T. Y., Mazur, C., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3230 · Cited by 738
Cellular uptake and trafficking of antisense oligonucleotides
Crooke, S. T., Wang, S., Vickers, T. A., Shen, W., & Liang, X.-H. (2017) · Nature Biotechnology · doi:10.1038/nbt.3779 · Cited by 582
Self-citationSwayze, E. E., Siwkowski, A. M., Wancewicz, E. V., Migawa, M. T., Wyrzykiewicz, T. K., Hung, G., Monia, B. P., & Bennett, A. C. F. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1071 · Cited by 469
Self-citationTopoisomerases facilitate transcription of long genes linked to autism
King, I. F., Yandava, C. N., Mabb, A. M., Hsiao, J. S., Huang, H.-S., Pearson, B. L., Calabrese, J. M., Starmer, J., Parker, J. S., Magnuson, T., et al. (2013) · Nature · doi:10.1038/nature12504 · Cited by 438
Molecular Mechanisms of Antisense Oligonucleotides
Crooke, S. T. (2017) · Nucleic Acid Therapeutics · doi:10.1089/nat.2016.0656 · Cited by 396
Self-citationDetermination of the Role of the Human RNase H1 in the Pharmacology of DNA-like Antisense Drugs
Wu, H., Lima, W. F., Zhang, H., Fan, A., Sun, H., & Crooke, S. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311683200 · Cited by 349
Self-citationEffect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding.
Brown, D. A., Kang, S. H., Gryaznov, S. M., DeDionisio, L., Heidenreich, O., Sullivan, S., Xu, X., & Nerenberg, M. I. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47090-1 · Cited by 336
PSF and p54nrb/NonO – multi‐functional nuclear proteins
Shav-Tal, Y., & Zipori, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03447-6 · Cited by 336
Frazier, K. S. (2015) · Toxicologic Pathology · doi:10.1177/0192623314551840 · Cited by 334
Liang, X.-H., Sun, H., Nichols, J. G., & Crooke, S. T. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.06.002 · Cited by 292
Self-citationGao, W. Y., Han, F. S., Storm, C., Egan, W., & Cheng, Y. C. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08861-3 · Cited by 232
Burel, S. A., Hart, C. E., Cauntay, P., Hsiao, J., Machemer, T., Katz, M., Watt, A., Bui, H.-H., Younis, H., Sabripour, M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1210 · Cited by 216
Self-citationLiang, X.-H., Sun, H., Shen, W., & Crooke, S. T. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv143 · Cited by 182
Self-citationBurdick, A. D., Sciabola, S., Mantena, S. R., Hollingshead, B. D., Stanton, R., Warneke, J. A., Zeng, M., Martsen, E., Medvedev, A., Makarov, S. S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku142 · Cited by 178
Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders
Calo, E., Gu, B., Bowen, M. E., Aryan, F., Zalc, A., Liang, J., Flynn, R. A., Swigut, T., Chang, H. Y., Attardi, L. D., et al. (2018) · Nature · doi:10.1038/nature25449 · Cited by 166
Thomas, M. P., Liu, X., Whangbo, J., McCrossan, G., Sanborn, K. B., Basar, E., Walch, M., & Lieberman, J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.026 · Cited by 161
Kasuya, T., Hori, S.-I., Watanabe, A., Nakajima, M., Gahara, Y., Rokushima, M., Yanagimoto, T., & Kugimiya, A. (2016) · Scientific Reports · doi:10.1038/srep30377 · Cited by 119
Kamola, P. J., Kitson, J., Turner, G., Maratou, K., Eriksson, S., Panjwani, A. A., Warnock, L. C., Douillard‐Guilloux, G., Moores, K., Koppe, E. L., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv857 · Cited by 118
Shen, W., Hoyos, C. L. D., Sun, H., Vickers, T. A., Liang, X., & Crooke, S. T. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky060 · Cited by 115
Self-citationLoss of Sfpq Causes Long-Gene Transcriptopathy in the Brain
Takeuchi, A., Iida, K., Tsubota, T., Hosokawa, M., Denawa, M., Brown, J. B., Ninomiya, K., Ito, M., Kimurâ, H., Abe, T., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.141 · Cited by 114
Chemical Modification Study of Antisense Gapmers
Stanton, R. V., Sciabola, S., Salatto, C. T., Weng, Y., Moshinsky, D., Little, J., Walters, E., Kreeger, J. M., DiMattia, D. A., Chen, T. X., et al. (2012) · Nucleic Acid Therapeutics · doi:10.1089/nat.2012.0366 · Cited by 111
2′-Fluoro-modified phosphorothioate oligonucleotide can cause rapid degradation of P54nrb and PSF
Shen, W., Liang, X., Sun, H., & Crooke, S. T. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv298 · Cited by 111
Self-citationLima, W. F., Murray, H. M., Damle, S. S., Hart, C. E., Hung, G., Hoyos, C. L. D., Liang, X., & Crooke, S. T. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw350 · Cited by 107
Self-citationMutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects
Study, T. D., Mircsof, D., Langouët, M., Rio, M., Moutton, S., Siquier-Pernet, K., Bôle‐Feysot, C., Cagnard, N., Nitschké, P., Gaspar, L., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4169 · Cited by 104
Phosphorothioate oligonucleotides can displaceNEAT1RNA and form nuclear paraspeckle-like structures
Shen, W., Liang, X., & Crooke, S. T. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku579 · Cited by 103
Self-citationLiang, X., Shen, W., Sun, H., Prakash, T. P., & Crooke, S. T. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku484 · Cited by 94
Self-citationVickers, T. A., & Crooke, S. T. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv920 · Cited by 87
Self-citationEfficient Synthesis and Biological Evaluation of 5′-GalNAc Conjugated Antisense Oligonucleotides
Østergaard, M. E., Yu, J., Kinberger, G. A., Wan, W. B., Migawa, M. T., Vasquez, G., Schmidt, K., Gaus, H. J., Murray, H. M., Low, A., et al. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00265 · Cited by 82
Self-citationPhosphorothioate Antisense Oligonucleotides Induce the Formation of Nuclear Bodies
Lorenz, P., Baker, B. F., Bennett, C. F., & Spector, D. L. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.5.1007 · Cited by 79
Liang, X., Shen, W., Sun, H., Kinberger, G. A., Prakash, T. P., Nichols, J. G., & Crooke, S. T. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw144 · Cited by 79
Self-citationDieckmann, A., Hagedorn, P., Burki, Y., Brügmann, C., Berrera, M., Ebeling, M., Singer, T., & Schuler, F. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.11.004 · Cited by 77
Wang, S., Allen, N., Vickers, T. A., Revenko, A. S., Sun, H., Liang, X., & Crooke, S. T. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky145 · Cited by 75
Self-citationDevelopment of a Quantitative BRET Affinity Assay for Nucleic Acid-Protein Interactions
Vickers, T. A., & Crooke, S. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161930 · Cited by 74
Self-citationShen, W., Sun, H., Hoyos, C. L. D., Bailey, J., Liang, X., & Crooke, S. T. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx710 · Cited by 71
Self-citationBailey, J., Shen, W., Liang, X., & Crooke, S. T. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx709 · Cited by 70
Self-citationStrategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense Drugs
Kamola, P. J., Maratou, K., Wilson, P. A., Rush, K., Mullaney, T., McKevitt, T. P., Evans, P., Ridings, J. E., Chowdhury, P., Roulois, A., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.07.003 · Cited by 67
Human RNase H1 Is Associated with Protein P32 and Is Involved in Mitochondrial Pre-rRNA Processing
Wu, H., Sun, H., Liang, X., Lima, W. F., & Crooke, S. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071006 · Cited by 60
Self-citationKakiuchi-Kiyota, S., Koza‐Taylor, P., Mantena, S. R., Nelms, L. F., EnayetAllah, A. E., Hollingshead, B. D., Burdick, A. D., Reed, L. A., Warneke, J. A., Whiteley, L. O., et al. (2013) · Toxicological Sciences · doi:10.1093/toxsci/kft278 · Cited by 58
Differences in rRNA metabolism of primary and SV40-transformed human fibroblasts
Liebhaber, S. A., Wolf, S. F., & Schlessinger, D. (1978) · Cell · doi:10.1016/0092-8674(78)90143-5 · Cited by 55
Sewing, S., Boess, F., Moisan, A., Bertinetti‐Lapatki, C., Minz, T., Hedtjaern, M., Tessier, Y., Schuler, F., Singer, T., & Roth, A. B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159431 · Cited by 39
The Medicinal Chemistry of Oligonucleotides
Swayze, E. E., & Bhat, B. (2007) · CRC Press eBooks · doi:10.1201/9780849387951.ch6 · Cited by 39
Shen, W., Liang, X., Sun, H., Hoyos, C. L. D., & Crooke, S. T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173494 · Cited by 31
Self-citationKakiuchi-Kiyota, S., Whiteley, L. O., Ryan, A. M., & Mathialagan, N. (2015) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0576 · Cited by 30
Electronic Structures of LNA Phosphorothioate Oligonucleotides
Bohr, H. G., Shim, I., Stein, C. A., Ørum, H., Hansen, H. F., & Koch, T. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.05.011 · Cited by 29
Quantum Mechanical Studies of DNA and LNA
Koch, T., Shim, I., Lindow, M., Ørum, H., & Bohr, H. G. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0465 · Cited by 25
Cited by
Therapeutic siRNA: state of the art
Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., & Liang, X.-J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0207-x · Cited by 1,586
Self-citationDrug delivery systems for RNA therapeutics
Paunovska, K., Loughrey, D., & Dahlman, J. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-021-00439-4 · Cited by 1,349
Antisense technology: an overview and prospectus
Crooke, S. T., Baker, B. F., Crooke, R. M., & Liang, X.-H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00162-z · Cited by 775
Self-citationTherapeutic siRNA: State-of-the-Art and Future Perspectives
Friedrich, M., & Aigner, A. (2022) · BioDrugs · doi:10.1007/s40259-022-00549-3 · Cited by 396
Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
Hammond, S. M., Aartsma‐Rus, A., Alves, S., Borgos, S. E., Buijsen, R. A. M., Collin, R. W. J., Covello, G., Denti, M. A., Desviat, L. R., Echevarría, L., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013243 · Cited by 388
Metadata
- Authors
- Shen, W., De Hoyos, C. L., Migawa, M. T., Vickers, T. A., Sun, H., Low, A., Bell, T. A., Rahdar, M., Mukhopadhyay, S., Hart, C. E., Bell, M., Riney, S., Murray, S. F., Greenlee, S., Crooke, R. M., Liang, X.-H., Seth, P. P., & Crooke, S. T.
- Venue
- Nature Biotechnology
- Published
- 2019-04-29
- Volume
- 37
- Issue
- 6
- Pages
- 640-650
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2943158117
- Cited by
- 345
- References
- 47
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.